Kemin’s Neumentix Spearmint Extract for Brain Health Obtains Self-Affirmed GRAS Status
Kemin Industries announced that after an extensive review by an independent panel of experts, the water-extracted spearmint ingredient can now be used in a variety of functional food and beverage applications, per FDA safety criteria.
Photo © iStockphoto.com/Yakobchuk
Kemin Industries’ (Des Moines, IA) spearmint extract ingredient Neumentix Phenolic Complex K110-42, targeting cognitive health, has now obtained self-affirmed Generally Recognized as Safe (GRAS) status. The company announced that, after an extensive review by an independent panel of experts, the water-extracted spearmint ingredient can now be used in a variety of functional food and beverage applications, per FDA safety criteria.
The ingredient contains more than 50 phenolic constituents, including non-GMO lines of polyphenol-rich spearmint extract developed by Kemin. According to the supplier, clinical studies have shown that Neumentix supports cognitive health, working memory performance, and healthy sleep patterns in adults. “We are seeing increased demand for foods and supplements that can naturally help people increase their productivity throughout the day,” said Kim Colletti, global cognition product manager at Kemin Human Health and Nutrition, in a press release.
Anita Noria, president of Kemin, added: “The Neumentix GRAS status enables our customers to expand into the functional foods market and help further improve the lives of consumers by offering cognitive-health benefits.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
